Skip to content
healthcare.dev

OLANZAPINE

NDC 13668-170, OLANZAPINE, tablet, from Torrent Pharmaceuticals Limited.

Product NDC
13668-170
Status
Listed
Labeler
Torrent Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091434
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13668-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE15 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
13668-170-0113668017001100 TABLET in 1 BOTTLE (13668-170-01)
13668-170-0513668017005500 TABLET in 1 BOTTLE (13668-170-05)
13668-170-10136680170101000 TABLET in 1 BOTTLE (13668-170-10)
13668-170-301366801703030 TABLET in 1 BOTTLE (13668-170-30)
13668-170-601366801706060 TABLET in 1 BOTTLE (13668-170-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2cb1bebe-0ced-46d8-bf21-c28a9acc4a15

Use it

Look up 13668-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13668-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13668-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.